In terms of PCOS, GLP-1 receptor agonists have been found to reduce PCO morphology, decrease biochemical hyperandrogenism, and improve menstrual regularity and ovulatory function [33]. The gene discussed is GLP1R; the disease is polycystic ovary syndrome.